Subscribe to RSS
DOI: 10.1055/s-2007-970140
© Georg Thieme Verlag KG Stuttgart · New York
Bipolar Switching after Carbamazepine Withdrawal
Publication History
received 5. 9. 2006
accepted 8. 1. 2007
Publication Date:
19 April 2007 (online)

Introduction
Anticonvulsants such as the dibenzazepine derivative carbamazepine (CBZ) are effective alternatives to lithium in phase prophylaxis of bipolar disorder, particularly in the elderly [1], and in case of medical comorbidity [5]. It is well established that lithium withdrawal may precipitate recurrence of manic symptoms in bipolar patients [2]. However, rebound-affective episodes in such patients upon discontinuation of CBZ have not been recognized till to date. Here we describe a case of mania induced in a bipolar depressive patient following cessation of long-term CBZ treatment.
References
- 1 Akiskal HS, Fuller MA, Hirschfeld RM, Keck Jr PE, Ketter TA, Weisler RH. Reassessing carbamazepine in the treatment of bipolar patients: clinical implications of new data. CNS Spectr. 2005; 10 ((6 Suppl 5)) 1-13
- 2 Cavanagh J, Smyth R, Goodwin GM. Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand. 2004; 109 91-95
- 3 Jess GE, Smith DJ, MacKenzie C, Crawford C. Carbamazepine and rebound mania. Am J Psychiatry. 2004; 161 2132-2133
- 4 Macritichie KAN, Hunt NJ. Does “rebound mania” occur after stopping carbamazepine? A pilot study. J Psychopharmacol. 2000; 14 266-268
- 5 Mouaffak F, Gourevitch R, Baup N, Loo H, Olie JP. Interrelations between lithium therapy, auto-immune thyroiditis and TSH. A case report. Pharmacopsychiatry. 2006; 39 77-78
- 6 Scull D, Trimble MR. Mania precipitated by carbamazepine withdrawal. Br J Psychiatry. 1995; 167 698
Correspondence
C. Lange-Asschenfeldt
Department of Psychiatry and Psychotherapy
Division of Geriatric Psychiatry
Heinrich Heine University
Bergische Landstr. 2
40629 Düsseldorf
Phone: + 49/211/922 42 15
Fax: + 49/211/922 42 13
Email: christian.lange-asschenfeldt@lvr.de